-
THYROID 2024 10.1089/thy.2024.0270
Graves' Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study
Cho, YY; Kim, B; Jin, SM; Jung, CH; Mok, JO; Kim, SW; Chung, JH; Han, KD; Kim, TH
View PubMed
-
EUR THYROID J 2024 10.1530/ETJ-23-0255
The association between BMI and BRAFV600E mutation may differ by primary tumor size
Park, H; Heo, J; Ryu, HJ; Kim, MJ; Oh, YL; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
CANCER IMMUNOL IMMUN 2024 10.1007/s00262-024-03852-w
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer
Kim, HI; Kim, WG; Kim, M; Ko, NG; Jin, M; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Choi, YL; Jeon, MJ; Kim, TY; Kim, WB; Kim, SW; Lee, DH; Jang, SJ; Kim, SW; Chung, JH; Kim, TH; Lee, SH
View PubMed
-
CANCER RES TREAT 2024 10.4143/crt.2023.1278
Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF V600E-Mutated Thyroid Cancer
Jeon, Y; Park, S; Lee, SH; Kim, TH; Kim, SW; Ahn, MJ; Jung, HA; Chung, JH
View PubMed
-
ENDOCRINOL METAB 2024 10.3803/EnM.2023.1896
Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer
Ryu, HJ; Choi, MS; Park, H; Kim, TH; Chung, JH; Park, SY; Kim, SW
View PubMed
-
SCI REP-UK 2024 10.1038/s41598-024-66351-z
Role of ultrasound in predicting telomerase reverse transcriptase (TERT) promoter mutation in follicular thyroid carcinoma
Kim, MK; Park, H; Oh, YL; Shin, JH; Kim, TH; Hahn, SY
View PubMed
-
SCI REP-UK 2024 10.1038/s41598-024-66096-9
The association between TSH and thyroid hormones in the normal or subclinical dysfunction range with left ventricular diastolic dysfunction
Jun, JE; Kim, TH; Kim, SW; Chung, JH; Kim, JH; Lee, YB; Kang, MR
View PubMed
-
ENDOCRINOL METAB 2024 10.3803/EnM.2023.1863
Clinical Manifestations of Malignant Struma Ovarii: A Retrospective Case Series in a Tertiary Hospital in Korea
Ryu, HJ; Leem, D; Yoo, JH; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
KOREAN J RADIOL 2024 10.3348/kjr.2023.0461
Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation
Kim, MK; Park, H; Oh, YL; Shin, JH; Kim, TH; Hahn, SY
View PubMed
-
PLOS ONE 2023 10.1371/journal.pone.0294145
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma
Heo, J; Lee, S; Park, J; Yang, HR; Park, H; Ki, CS; Oh, YL; Kim, HI; Kim, SW; Chung, JH; Kim, K; Kim, TH
View PubMed
-
ENDOCRINE 2023 10.1007/s12020-023-03510-8
Mortality rate and causes of death in papillary thyroid microcarcinoma
Heo, J; Ryu, HJ; Park, H; Kim, TH; Kim, SW; Oh, YL; Chung, JH
View PubMed
-
ANN SURG ONCOL 2023 10.1245/s10434-023-14357-8
Letter to Editor in Response to Article Entitled Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promotor Mutational Status
Park, H; Kim, TY; Kim, TH; Kim, JH
View PubMed
-
SCI REP-UK 2023 10.1038/s41598-023-42907-3
Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy
Park, H; Ryu, HJ; Heo, J; Chung, MK; Son, YI; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Kim, SW; Chung, JH; Kim, JS; Kim, TH
View PubMed
-
SCI REP-UK 2023 10.1038/s41598-023-30162-5
Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma
Cho, S; Kim, H; Oh, YL; Hahn, SY; Kim, TH; Shin, JH
View PubMed
-
J PEDIATR SURG 2023 10.1016/j.jpedsurg.2022.07.010
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis
Back, K; Kim, TH; Lee, JY; Kim, JS; Choe, JH; Oh, YL; Cho, A; Kim, JH
View PubMed
-
ANN SURG ONCOL 2023 10.1245/s10434-022-13089-5
Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status
Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH
View PubMed
-
THYROID 2023 10.1089/thy.2022.0216
Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea
Kim, HI; Kim, TH; Kim, H; Kim, SW; Hahm, JR; Chung, JH
View PubMed
-
ANN SURG ONCOL 2023 10.1245/s10434-023-13146-7
ASO Visual Abstract: Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status
Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH
View PubMed
-
ENDOCRINOL METAB 2022 10.3803/EnM.2022.1591
Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea
Heo, J; Kim, SM; Ryu, HJ; Park, H; Kim, TH; Chung, JH; Park, HD; Kim, SW
View PubMed
-
FRONT ENDOCRINOL 2022 10.3389/fendo.2022.1032764
Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study
Cho, YY; Kim, B; Choi, D; Kim, CH; Shin, DW; Kim, JS; Park, SJ; Kim, SW; Chung, JH; Han, K; Kim, TH
View PubMed
-
ULTRASONOGRAPHY 2022 10.14366/usg.21264
Ultrasonographic characteristics of H?rthle cell neoplasms: prediction of malignancy
Kim, MJ; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Lim, Y; Lee, SHY
View PubMed
-
EPILEPSIA 2022 10.1111/epi.17407
The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy
Park, H; Heo, J; Kim, MJ; Lee, JH; Kim, MS; Jin, DK; Kim, TH; Chung, JH; Cho, SY; Kim, SW
View PubMed
-
ENDOCRINOL METAB 2022 10.3803/EnM.2022.1477
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
Yang, HR; Park, H; Ryu, HJ; Heo, J; Kim, JS; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Jang, HW; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
ENDOCRINOL METAB 2022 10.3803/EnM.2022.1429
Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women
Park, H; Yang, H; Heo, J; Jang, HW; Chung, JH; Kim, TH; Min, YK; Kim, SW
View PubMed
-
ENDOCRINOL METAB 2022 10.3803/EnM.2021.1333
Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
Cho, YY; Kim, B; Shin, DW; Jang, HR; Kim, BY; Jung, CH; Kim, JH; Kim, SW; Chung, JH; Han, K; Kim, TH
View PubMed
-
ENDOCR-RELAT CANCER 2022 10.1530/ERC-21-0403
Effect of TSH levels during active surveillance of PTMC according to age
Kim, HI; Jin, M; Ko, NG; Oh, YL; Shin, JH; Kim, JH; Kim, JS; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, WG; Kim, TH
View PubMed
-
THYROID 2022 10.1089/thy.2021.0675
Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study of 10 Million People
Yeo, Y; Shin, DW; Han, K; Kim, D; Kim, TH; Chun, S; Jeong, SM; Song, YM
View PubMed
-
ULTRASONOGRAPHY 2022 10.14366/usg.21200
What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography?
Kim, H; Oh, YL; Chung, JH; Hahn, SY; Park, KW; Kim, TH; Shin, JH
View PubMed
-
CLIN ENDOCRINOL 2022 10.1111/cen.14698
Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy
Park, H; Park, J; Yoo, H; Kim, S; Koh, JH; Jee, JH; Min, YK; Chung, JH; Kim, TH; Kang, M; Kim, SW
View PubMed
-
CANCERS 2021 10.3390/cancers13122943 2021
Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
Park1, J; Lee, S; Park, J; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, K; Kim, TH
View PubMed
-
CANCERS 2021 10.3390/cancers13102343 2021
Changes in Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study
Yeo1, Y; Han, K; Shin, DW; Kim, D; Jeong, SM; Chun, S; Choi, IY; Jeon, KH; Kim, TH
View PubMed
-
FRONT ENDOCRINOL (LAUSANNE) 2021 10.3389/fendo.2021.681148 2021
Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors
Park1, J; Park, H; Kim, TH; Kim, SW; Jang, HW; Chung, JH
View PubMed
-
CANCERS 2021 10.3390/cancers13081948 2021
Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study
Lee1, YB; Oh, YL; Shin, JH; Kim, SW; Chung, JH; Min, YK; Hahn, SY; Kim, TH
View PubMed
-
ENDOCRINE 2021 10.1007/s12020-021-02725-x 2021
The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea
Park1, SY; Kim, BH; Kim, M; Hong, AR; Park, J; Park, H; Choi, MS; Kim, TH; Kim, SW; Kang, HC; Chung, JH
View PubMed
-
CANCERS 2021 10.3390/cancers13081913 2021
Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma
Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
View PubMed
-
CANCERS 2021 10.3390/cancers13040648 2021
TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
Park1, J; Lee, S; Kim, K; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
CANCERS 2021 10.3390/cancers13225842
Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
Kim, J; Park, J; Park, H; Choi, MS; Jang, HW; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-01898-9
Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels
Kim, H; Jung, J; Cho, YS; Choi, JY; Park, H; You-Bin Lee; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
FRONT ENDOCRINOL 2021 10.3389/fendo.2021.749973
Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
Park, H; Park, SY; Park, J; Choe, JH; Chung, MK; Woo, SY; Choi, JY; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
ENDOCRINE 2021 10.1007/s12020-021-02864-1
Core needle biopsy and ultrasonography are superior to fine needle aspiration in the management of follicular variant papillary thyroid carcinomas
Kim, JY; Chang, S; Kwon, AY; Park, EY; Kim, TH; Choi, S; Lee, M; Oh, YL
View PubMed
-
MODERN PATHOL 2021 10.1038/s41379-021-00907-6
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
Park, H; Shin, HC; Yang, H; Heo, J; Ki, CS; Kim, HS; Kim, JH; Hahn, SY; Chung, YJ; Kim, SW; Chung, JH; Oh, YL; Kim, TH
View PubMed
-
CANCERS 2021 10.3390/cancers13184670
Long-Term Outcomes and Causes of Death among Medullary Thyroid Carcinoma Patients with Distant Metastases
Park, H; Yang, H; Heo, J; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
THYROID 2021 10.1089/thy.2021.0094
Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea
Jin, M; Kim, HI; Ha, J; Jeon, MJ; Kim, WG; Lim, DJ; Kim, TY; Chung, JH; Shong, YK; Kim, TH; Kim, WB
View PubMed
-
THYROID 2021 10.1089/thy.2020.0756
Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease
Kim, J; Choi, MS; Park, J; Park, H; Jang, HW; Choe, JH; Kim, JH; Kim, JS; Cho, YS; Choi, JY; Kim, TH; Chung, JH; Kim, SW
View PubMed
-
ANN SURG ONCOL 2021 10.1245/s10434-021-10383-6
Surgeon Volume and Long-Term Oncologic Outcomes in Patients with Medullary Thyroid Carcinoma
Park, H; Kim, HI; Choe, JH; Chung, MK; Son, YI; Hahn, SY; Hwang, NY; Woo, SY; Kim, SW; Chung, JH; Kim, TH; Kim, JS
View PubMed
-
CANCERS 2020 10.3390/cancers12102894 2020
Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma
Park1, H; Park, J; Choi, MS; Kim, J; Kim, H; Shin, JH; Kim, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
CANCERS 2020 10.3390/cancers12082323 2020
Clinical Course from Diagnosis to Death in Patients with Well-Differentiated Thyroid Cancer
Park1, H; Park, J; Park, SY; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
INT J MOL SCI 2020 10.3390/ijms21165629 2020
Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules A Prospective Study ofBRAF-Prevalent Population
Cho1, YY; Park, SY; Shin, JH; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Yim, HS; Kim, YL; Ki, CS; Kim, TH; Chung, JH; Kim, SW
View PubMed
-
CANCERS 2020 10.3390/cancers12030625 2020
Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer
Kim1, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH
View PubMed
-
NUCL MED COMMUN 2020 10.1097/MNM.0000000000001138 2020
The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study
Park1, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW
View PubMed
-
CLIN ENDOCRINOL 2020 10.1111/cen.14167 2020
Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?
Park1, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH
View PubMed
-
ACTA RADIOL 2020 10.1177/0284185119847677 2020
Comparison of ultrasonography and CT for preoperative nodal assessment of patients with papillary thyroid cancer: diagnostic performance according to primary tumor size
Yang1, SY; Shin, JH; Hahn, SY; Lim, Y; Hwang, SY; Kim, TH; Kim, JS
View PubMed
-
SCI REP-UK 2019 10.1038/s41598-019-55370-w 2019
Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer
Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
THYROID 2019 10.1089/thy.2019.0261 2019
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis
Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH
View PubMed
-
THYROID 2019 10.1089/thy.2019.0246 2019
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
Oh1, HS; Shin, DY; Kim, M; Park, SY; Kim, TH; Kim, BH; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Lim, DJ; Kim, WG
View PubMed
-
EUR J NUTR 2019 10.1007/s00394-018-1837-4 2019
Non-immune-related hypothyroidism and its relationship with excess iodine
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH
View PubMed
-
THYROID 2019 10.1089/thy.2018.0541 2019
Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL
View PubMed
-
ENDOCRINE 2019 10.1007/s12020-018-1807-x 2019
Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW
View PubMed
-
ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014 2019
Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma
Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH
View PubMed
-
EUR J NUTR 2019 10.1007/s00394-017-1587-8 2019
Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH
View PubMed
-
THYROID 2018 10.1089/thy.2018.0263 2018
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH
View PubMed
-
J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386 2018
Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma
Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029 2018
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study
Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG
View PubMed
-
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008 2018
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study
Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG
View PubMed
-
SCI REP-UK 2018 10.1038/s41598-018-31955-9 2018
Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL
View PubMed
-
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002 2018
Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles
Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH
View PubMed
-
BRIT J SURG 2018 10.1002/bjs.10830 2018
Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma
Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH
View PubMed
-
THYROID 2018 10.1089/thy.2017.0550 2018
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea
Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW
View PubMed
-
KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051 2018
Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area
Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY
View PubMed
-
ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021 2018
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis
Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH
View PubMed
-
HISTOPATHOLOGY 2018 10.1111/his.13401 2018
Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma
Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL
View PubMed
-
ANN INTERN MED 2018 10.7326/M17-1398 2018
Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study
Seo1, GH; Kim, TH; Chung, JH
View PubMed
-
THYROID 2018 10.1089/thy.2017.0356 2018
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
View PubMed
-
THYROID 2018 10.1089/thy.2017.0356 2018
Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study
Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
View PubMed
-
BRIT J SURG 2018 10.1002/bjs.10655 2018
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH
View PubMed
-
J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775 2018
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
View PubMed
-
PLoS One 2018 10.1371/journal.pone.0190738 2018
Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)
Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW
View PubMed
-
CLIN ENDOCRINOL 2018 10.1111/cen.13489 2018
Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up
Sohn1, SY; Kim, HI; Kim, YN; Kim, TH; Kim, W; Chung, JH
View PubMed
-
Oncoimmunology 2018 10.1080/2162402X.2017.1375642 2018
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer
Kim1, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH
View PubMed
-
THYROID 2018 10.1089/thy.2017.0214 2018
Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer
Jeon1, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.22430 2017
Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
Hahn1, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH
View PubMed
-
SCI REP-UK 2017 10.1038/s41598-017-17176-6 2017
Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer
Kim1, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
View PubMed
-
Cancer Med 2017 10.1002/cam4.1160 2017
Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH
View PubMed
-
ENDOCRINE 2017 10.1007/s12020-017-1381-7 2017
Validation of dynamic risk stratification in pediatric differentiated thyroid cancer
Sohn1, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH
View PubMed
-
THYROID 2017 10.1089/thy.2016.0677 2017
Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma
Hahn1, SY; Shin, JH; Oh, YL; Kim, TH; Lim, Y; Choi, JS
View PubMed
-
CLIN ENDOCRINOL 2017 10.1111/cen.13344 2017
Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer
Kim1, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW
View PubMed
-
ENDOCRINE 2017 10.1007/s12020-017-1363-9 2017
Hormetic effect of triiodothyronine in metabolically healthy obese persons
Jun1, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK
View PubMed
-
ORAL ONCOL 2017 10.1016/j.oraloncology.2017.06.004 2017
Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma
Kim1, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH
View PubMed
-
ENDOCRINE 2017 10.1007/s12020-017-1340-3 2017
Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer
Kim1, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH
View PubMed
-
PLoS One 2017 10.1371/journal.pone.0182090 2017
Subclinical thyroid dysfunction and risk of carotid atherosclerosis
Kim1, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW
View PubMed
-
THYROID 2017 10.1089/thy.2016.0648 2017
Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma
Kim1, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH
View PubMed
-
Osteoporos Int. 2017 Apr;28(4):1377-1384. doi: 10.1007/s00198-016-3892-0. Epub 2017 Feb 10. 2017
Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis
Lee DY11,2, Jee JH3, Cho YY1, Jang JY1, Yu TY1, Kim TH1, Hong YJ1, Hong WJ1, Jin SM1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK4.
View PubMed
-
Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2. 2017
Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M11, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.
View PubMed
-
Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12. 2017
Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area
Lee YB11, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.
View PubMed
-
Endocrine. 2017 Feb;55(2):503-512. doi: 10.1007/s12020-016-1138-8. Epub 2016 Oct 5. 2017
The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects
Lee DY11,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.
View PubMed
-
Endocr Relat Cancer. 2017 Feb;24(2):97-106. doi: 10.1530/ERC-16-0421. 2017
Comprehensive screening for PD-L1 expression in thyroid cancer
Ahn S11, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.
View PubMed
-
PLoS One. 2017 Jan 12;12(1):e0169775. doi: 10.1371/journal.pone.0169775. eCollection 2017. 2017
Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication
Kim HI11, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.
View PubMed
-
Ann Lab Med. 2017 Jan;37(1):63-65. doi: 10.3343/alm.2017.37.1.63. 2017
First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant
Cho YY11,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.
View PubMed
-
Thyroid. 2017 Jan;27(1):29-38. doi: 10.1089/thy.2016.0171. Epub 2016 Dec 9. 2017
Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study
Jun JE11, Jee JH2, Bae JC3, Jin SM1, Hur KY1, Lee MK1, Kim TH1, Kim SW1, Kim JH1.
View PubMed
-
Endocr Relat Cancer. 2016 Oct;23(10):813-23. doi: 10.1530/ERC-16-0219. Epub 2016 Aug 15. 2016
TERT promoter mutations and long-term survival in patients with thyroid cancer
Kim TH11, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.
View PubMed
-
Head Neck. 2016 Oct;38(10):1501-8. doi: 10.1002/hed.24469. Epub 2016 Apr 7. 2016
Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence
Cho YY11, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.
View PubMed
-
Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11. 2016
Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications
Joung JY11, Kim TH1, Jeong DJ1, Park SM1, Cho YY1, Jang HW2, Jung YY3, Oh YL3, Yim HS4, Kim YL4, Chung JH1, Ki CS5, Kim SW1.
View PubMed
-
Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18. 2016
Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques
Kim TH11, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.
View PubMed
-
Nutr Res Pract. 2016 Apr;10(2):167-74. doi: 10.4162/nrp.2016.10.2.167. Epub 2015 Dec 11. 2016
Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region
Ju DL11, Park YJ2, Paik HY3, Kim MJ4, Park S5, Jung KY6, Kim TH7, Choi HS8, Song YJ4.
View PubMed
-
PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015. 2015
A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels
Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.
View PubMed
-
Diabet Med. 2015 Feb;32(2):274-9. doi: 10.1111/dme.12607. Epub 2014 Oct 29. 2015
Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring
Jin SM11, Kim TH, Oh S, Baek J, Joung JY, Park SM, Cho YY, Sohn SY, Hur KY, Lee MS, Lee MK, Kim JH.
View PubMed
